top of page

FDA approves Wellstat's Vistogard for chemotherapy overdose

The US Food and Drug Administration (FDA) has approved Wellstat Therapeutics' Vistogard (uridine triacetate) to treat overdose of fluorouracil or capecitabine, which are administered for several malignancies.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page